Lv2
150 积分 2024-10-13 加入
Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study
15天前
已完结
A randomized phase 2 study of neratinib with or without fulvestrant for patients with HER2-positive, estrogen receptor-positive metastatic breast cancer
19天前
已完结
Targeted delivery of neratinib/xanthan gum-capped calcium carbonate nanoparticles induces apoptosis through PI3K/AKT pathway in breast cancer mice model
20天前
已关闭
Molecular Classification of Breast Cancer
23天前
已完结
Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?
5个月前
已完结
Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer
6个月前
已关闭
Clinical efficacy of pyrotinib combined with chemotherapy for neoadjuvant treatment in HER2-positive breast cancer: a single-center study
6个月前
已完结
Pyrotinib treatment enhances the radiosensitivity in HER2-positive brain metastatic breast cancer patients
6个月前
已完结
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
10个月前
已完结
皖公网安备34019202002308
